Neurogastrx, Inc. Report issue

For profit Phase 2
Founded: Woburn Massachusetts United States (2012)

Organization Overview

First Clinical Trial
2020
NCT04303195
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Neurogastrx, Inc.